Literature DB >> 2145865

Ventricular arrhythmias in hypertensive left ventricular hypertrophy. Relationship to coronary artery disease, left ventricular dysfunction, and myocardial fibrosis.

J M McLenachan1, H J Dargie.   

Abstract

Ventricular arrhythmias occur with increased frequency in hypertensive patients with left ventricular hypertrophy (LVH). The relationships, however, between ventricular arrhythmias and coexistent coronary artery disease, left ventricular dysfunction and left ventricular fibrosis have not been examined in hypertensive LVH. We carried out coronary arteriography on fifteen hypertensive patients with LVH and nonsustained ventricular tachycardia (greater than or equal to 3 consecutive ventricular complexes) of whom nine (60%) were free of significant (greater than 50% stenosis) coronary disease. To identify other possible correlates of left ventricular arrhythmias, 28 patients with LVH, comprising 17 with ventricular tachycardia and 11 without ventricular arrhythmias, underwent quantitative assessment of left ventricular function (angiographic ejection fraction), left ventricular mass (echocardiography), and left ventricular fibrosis (endomyocardial biopsy). Ejection fraction was not significantly different between the two groups (53 +/- 8% v 62 +/- 2%, P = NS). However, left ventricular mass was significantly greater (442 +/- 28 g v 339 +/- 34 g, P less than .05) and percentage fibrosis significantly higher (19 +/- 4% v 3 +/- 1%, P less than .001) in those patients with ventricular tachycardia. Thus ventricular arrhythmias in hypertensive patients with LVH cannot be entirely attributed to coexistent coronary disease, nor to left ventricular dysfunction, but are related to the degree of cardiac hypertrophy and subendocardial fibrosis.

Entities:  

Mesh:

Year:  1990        PMID: 2145865     DOI: 10.1093/ajh/3.10.735

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  28 in total

Review 1.  Myocardial Interstitial Fibrosis in Nonischemic Heart Disease, Part 3/4: JACC Focus Seminar.

Authors:  Javier Díez; Arantxa González; Jason C Kovacic
Journal:  J Am Coll Cardiol       Date:  2020-05-05       Impact factor: 24.094

2.  Associations of electrocardiographic P-wave characteristics with left atrial function, and diffuse left ventricular fibrosis defined by cardiac magnetic resonance: The PRIMERI Study.

Authors:  Theingi Tiffany Win; Bharath Ambale Venkatesh; Gustavo J Volpe; Nathan Mewton; Patricia Rizzi; Ravi K Sharma; David G Strauss; Joao A Lima; Larisa G Tereshchenko
Journal:  Heart Rhythm       Date:  2014-10-14       Impact factor: 6.343

3.  Impaired left ventricular filling in hypertensive left ventricular hypertrophy as a marker of the presence of an arrhythmogenic substrate.

Authors:  P Palatini; G Maraglino; V Accurso; M Sturaro; G Toniolo; P Dovigo; S Baccillieri
Journal:  Br Heart J       Date:  1995-03

Review 4.  Recent Advances in Imaging of Hypertensive Heart Disease.

Authors:  Christopher L Schumann; Nicholas R Jaeger; Christopher M Kramer
Journal:  Curr Hypertens Rep       Date:  2019-01-14       Impact factor: 5.369

5.  Atrial fibrillation after cardiac surgery: a major morbid event?

Authors:  G H Almassi; T Schowalter; A C Nicolosi; A Aggarwal; T E Moritz; W G Henderson; R Tarazi; A L Shroyer; G K Sethi; F L Grover; K E Hammermeister
Journal:  Ann Surg       Date:  1997-10       Impact factor: 12.969

6.  Monitoring of Cardiac Remodeling in a Mouse Model of Pressure-Overload Left Ventricular Hypertrophy with [18F]FDG MicroPET.

Authors:  Andrei Todica; Nick L Beetz; Lisa Günther; Mathias J Zacherl; Ulrich Grabmaier; Bruno Huber; Peter Bartenstein; Stefan Brunner; Sebastian Lehner
Journal:  Mol Imaging Biol       Date:  2018-04       Impact factor: 3.488

7.  Clinical and echocardiographic correlates of plasma procollagen type III amino-terminal peptide levels in the community.

Authors:  Thomas J Wang; Martin G Larson; Emelia J Benjamin; Deborah A Siwik; Radwan Safa; Chao-Yu Guo; Diane Corey; Johan Sundstrom; Douglas B Sawyer; Wilson S Colucci; Ramachandran S Vasan
Journal:  Am Heart J       Date:  2007-08       Impact factor: 4.749

Review 8.  Understanding cardiac extracellular matrix remodeling to develop biomarkers of myocardial infarction outcomes.

Authors:  Signe Holm Nielsen; Alan J Mouton; Kristine Y DeLeon-Pennell; Federica Genovese; Morten Karsdal; Merry L Lindsey
Journal:  Matrix Biol       Date:  2017-12-14       Impact factor: 11.583

9.  Fragmented QRS complexes are associated with increased left ventricular mass in patients with essential hypertension.

Authors:  Hasan Kadi; Ayşe Kevser; Ahmet Ozturk; Fatih Koc; Koksal Ceyhan
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-07-30       Impact factor: 1.468

10.  Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality.

Authors:  Timothy C Wong; Kayla Piehler; Christopher G Meier; Stephen M Testa; Amanda M Klock; Ali A Aneizi; Jonathan Shakesprere; Peter Kellman; Sanjeev G Shroff; David S Schwartzman; Suresh R Mulukutla; Marc A Simon; Erik B Schelbert
Journal:  Circulation       Date:  2012-07-31       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.